schiff has invested in Ganeden Biotech, Inc.
Target Company Name:
Country:
Advisory:
Sector:
Partner:
Country:
Advisory:
Sector:
Partner:
Capital Raise for a U.S. based developer of proprietary probiotic strains
Sale of Ganeden, a U.S. based developer of proprietary probiotic strains, to Schiff
Advisor :
Brown Gibbons Lang & Company
Brown Gibbons Lang & Company
Experts who worked on this transaction
Loading...